SUPN - SVP at Supernus Pharmaceuticals Exercises Options Worth $55K | Benzinga
Frank Mottola, SVP at Supernus Pharmaceuticals (NASDAQ:SUPN), reported a large exercise of company stock options on November 16, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Mottola, SVP at Supernus Pharmaceuticals, a company in the Health Care sector, just exercised stock options worth 2,000 shares of SUPN stock with an exercise price of $9.24.
Supernus Pharmaceuticals shares are trading down 0.11% at $27.85 at the time of this writing on Friday morning. Since the current price is $27.85, this makes Mottola's 2,000 shares worth $55,700.
Now trade stocks online commission free with Charles Schwab, a trusted ...